These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 29371602)

  • 1. AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation.
    Gélinas R; Mailleux F; Dontaine J; Bultot L; Demeulder B; Ginion A; Daskalopoulos EP; Esfahani H; Dubois-Deruy E; Lauzier B; Gauthier C; Olson AK; Bouchard B; Des Rosiers C; Viollet B; Sakamoto K; Balligand JL; Vanoverschelde JL; Beauloye C; Horman S; Bertrand L
    Nat Commun; 2018 Jan; 9(1):374. PubMed ID: 29371602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swim-exercised mice show a decreased level of protein O-GlcNAcylation and expression of O-GlcNAc transferase in heart.
    Belke DD
    J Appl Physiol (1985); 2011 Jul; 111(1):157-62. PubMed ID: 21493720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excess Protein O-GlcNAcylation Links Metabolic Derangements to Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
    Prisco SZ; Rose L; Potus F; Tian L; Wu D; Hartweck L; Al-Qazazi R; Neuber-Hess M; Eklund M; Hsu S; Thenappan T; Archer SL; Prins KW
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased O-GlcNAcylation induces myocardial hypertrophy.
    Chen X; Zhang L; He H; Sun Y; Shen Q; Shi L
    In Vitro Cell Dev Biol Anim; 2020 Oct; 56(9):735-743. PubMed ID: 32996013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studying the Role of AMPK in Cardiac Hypertrophy and Protein Synthesis.
    Mailleux F; Beauloye C; Balligand JL; Horman S; Bertrand L
    Methods Mol Biol; 2018; 1732():321-342. PubMed ID: 29480485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAcylation involvement in high glucose-induced cardiac hypertrophy via ERK1/2 and cyclin D2.
    Ding F; Yu L; Wang M; Xu S; Xia Q; Fu G
    Amino Acids; 2013 Aug; 45(2):339-49. PubMed ID: 23665912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPK signaling pathway is rapidly activated by T3 and regulates the cardiomyocyte growth.
    Takano AP; Diniz GP; Barreto-Chaves ML
    Mol Cell Endocrinol; 2013 Aug; 376(1-2):43-50. PubMed ID: 23748029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
    Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
    J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GFAT1 phosphorylation by AMPK promotes VEGF-induced angiogenesis.
    Zibrova D; Vandermoere F; Göransson O; Peggie M; Mariño KV; Knierim A; Spengler K; Weigert C; Viollet B; Morrice NA; Sakamoto K; Heller R
    Biochem J; 2017 Mar; 474(6):983-1001. PubMed ID: 28008135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockage of O-linked GlcNAcylation induces AMPK-dependent autophagy in bladder cancer cells.
    Jin L; Yuan F; Dai G; Yao Q; Xiang H; Wang L; Xue B; Shan Y; Liu X
    Cell Mol Biol Lett; 2020; 25():17. PubMed ID: 32174982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2J2 and its metabolites (epoxyeicosatrienoic acids) attenuate cardiac hypertrophy by activating AMPKα2 and enhancing nuclear translocation of Akt1.
    Wang B; Zeng H; Wen Z; Chen C; Wang DW
    Aging Cell; 2016 Oct; 15(5):940-52. PubMed ID: 27416746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldolase promotes the development of cardiac hypertrophy by targeting AMPK signaling.
    Li Y; Zhang D; Kong L; Shi H; Tian X; Gao L; Liu Y; Wu L; Du B; Huang Z; Liang C; Wang Z; Yao R; Zhang Y
    Exp Cell Res; 2018 Sep; 370(1):78-86. PubMed ID: 29902536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consumption of a high fat diet promotes protein O-GlcNAcylation in mouse retina via NR4A1-dependent GFAT2 expression.
    Dai W; Dierschke SK; Toro AL; Dennis MD
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3568-3576. PubMed ID: 30254013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure.
    Lunde IG; Aronsen JM; Kvaløy H; Qvigstad E; Sjaastad I; Tønnessen T; Christensen G; Grønning-Wang LM; Carlson CR
    Physiol Genomics; 2012 Feb; 44(2):162-72. PubMed ID: 22128088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carnosol suppresses cardiomyocyte hypertrophy via promoting the activation of AMPK pathway.
    Tian Y; Liu R; Yang Q; Zhang J; Liu Z; Dong B; Gao J; Wan L
    Biochem Biophys Res Commun; 2024 Oct; 729():150343. PubMed ID: 38986259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPK regulates energy metabolism through the SIRT1 signaling pathway to improve myocardial hypertrophy.
    Dong HW; Zhang LF; Bao SL
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2757-2766. PubMed ID: 29771428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy.
    Facundo HT; Brainard RE; Watson LJ; Ngoh GA; Hamid T; Prabhu SD; Jones SP
    Am J Physiol Heart Circ Physiol; 2012 May; 302(10):H2122-30. PubMed ID: 22408028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RING-domain E3 ubiquitin ligase RNF146 promotes cardiac hypertrophy by suppressing the LKB1/AMPK signaling pathway.
    Sheng Z; Xu J; Li F; Yuan Y; Peng X; Chen S; Zhou R; Huang W
    Exp Cell Res; 2022 Jan; 410(1):112954. PubMed ID: 34856161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol prevents pathological but not physiological cardiac hypertrophy.
    Dolinsky VW; Soltys CL; Rogan KJ; Chan AY; Nagendran J; Wang S; Dyck JR
    J Mol Med (Berl); 2015 Apr; 93(4):413-25. PubMed ID: 25394677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule QF84139 ameliorates cardiac hypertrophy via activating the AMPK signaling pathway.
    Li XX; Zhang P; Yang Y; Wang JJ; Zheng YJ; Tan JL; Liu SY; Yan YM; Zhang YY; Cheng YX; Yang HT
    Acta Pharmacol Sin; 2022 Mar; 43(3):588-601. PubMed ID: 33967278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.